Veeva Systems (VEEV) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
4 May, 2026Executive summary
Annual meeting scheduled for June 17, 2026, with virtual participation and voting options for shareholders of record as of April 20, 2026.
Two main proposals: election of nine directors and ratification of KPMG LLP as independent auditor for fiscal year ending January 31, 2027.
Board recommends voting "FOR" all director nominees and auditor ratification.
Shareholder engagement reached holders of 40% of shares, with meetings covering governance, board composition, and executive compensation.
Initiated a $2 billion share repurchase program and continued focus on public benefit corporation (PBC) objectives.
Voting matters and shareholder proposals
Proposal One: Elect nine directors to serve until 2027; majority of votes cast required for election.
Proposal Two: Ratify KPMG LLP as independent auditor; majority of votes cast required for approval.
Shareholders can submit proposals and director nominations for the 2027 meeting, with proxy access for significant long-term holders.
Board of directors and corporate governance
Board consists of nine members, eight of whom are independent; diverse in gender and underrepresented communities.
Board committees: Audit, Compensation, Cybersecurity, and Nominating and Governance, all comprised of independent directors.
Recent governance enhancements include single-class voting, declassified board, proxy access, and special meeting rights.
Board leadership is separated from CEO role; independent Chair presides.
Annual board and committee evaluations conducted by third party.
Latest events from Veeva Systems
- Vote on nine directors and auditor ratification at the June 17, 2026 virtual annual meeting.VEEV
Proxy filing4 May 2026 - FY 2026 revenue and net income rose sharply, with robust outlook and accelerating AI-driven growth.VEEV
Q4 20265 Mar 2026 - All proposals were recommended for approval, with voting results to be filed publicly.VEEV
AGM 20243 Feb 2026 - Growth accelerates as unified platform, AI, and new products expand market share and customer value.VEEV
Baird 2024 Global Consumer, Technology & Services Conference1 Feb 2026 - Integrated platform and data innovation fuel durable growth and leadership in life sciences.VEEV
The 44th Annual William Blair Growth Stock Conference1 Feb 2026 - Q2 revenue up 15% year-over-year, with strong margins and raised FY2025 guidance.VEEV
Q2 202523 Jan 2026 - Vault CRM and unified platforms drive growth as life sciences invests in innovation.VEEV
Citi's 2024 Global TMT Conference22 Jan 2026 - 2030 revenue goal set at $6B, with organic growth and new market expansion as key drivers.VEEV
Investor Day 202415 Jan 2026 - AI-driven life sciences cloud growth targets $6B revenue and diversified leadership by 2030.VEEV
44th Annual J.P. Morgan Healthcare Conference13 Jan 2026